1177558-43-8 Usage
General Description
Tert-butyl 5-bromo-2-methylbenzylcarbamate is a chemical compound with the molecular formula C13H18BrNO2. It is a carbamate derivative and contains a tert-butyl group, a bromine atom, and a benzyl group. tert-butyl 5-bromo-2-methylbenzylcarbamate is often used in organic synthesis as a reagent or intermediate for the production of pharmaceuticals and agrochemicals. It has been shown to exhibit insecticidal and antimicrobial properties, making it a potential candidate for the development of new pesticides and antimicrobial agents. Tert-butyl 5-bromo-2-methylbenzylcarbamate is also used in research and industrial applications for its ability to undergo various chemical reactions and form complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 1177558-43-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,7,5,5 and 8 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1177558-43:
(9*1)+(8*1)+(7*7)+(6*7)+(5*5)+(4*5)+(3*8)+(2*4)+(1*3)=188
188 % 10 = 8
So 1177558-43-8 is a valid CAS Registry Number.
1177558-43-8Relevant articles and documents
Dual Pharmacophores - PDE4-Muscarinic Antagonistics
-
Page/Page column 48-49, (2009/08/18)
The present invention is directed to novel compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions and their use as dual chromaphores having inhibitory activity against PDE4 and muscarinic acetylcholine receptors (mAChRs), and thus being useful for treating respiratory diseases.
Dual Pharmacophores - PDE4-Muscarinic Antagonistics
-
Page/Page column 51, (2009/08/16)
The present invention is directed to novel compounds of Formula (I), pharmaceutical compositions and their use in therapy, for example as inhibitors of phosphodiesterase type IV (PDE4) and as antagonists of muscarinic acetylcholine receptors (mAChRs), in the treatment of/and or prophylaxis of respiratory diseases, including antiinflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis (e.g. allergic rhinitis), atopic dermatitis or psoriasis.
